Core Viewpoint - Hengyi Petrochemical reported a total operating revenue of 55.96 billion yuan and a net profit attributable to shareholders of 0.227 billion yuan for the first half of 2025, highlighting the steady progress of its Brunei refining project and the 1.2 million tons caprolactam-polyamide project in Guangxi, which are expected to strengthen its position as a global leader in the integrated "refining-chemical-fiber" industry chain [1] Group 1: Financial Performance - In the first half of 2025, Hengyi Petrochemical achieved total operating revenue of 55.96 billion yuan and a net profit of 0.227 billion yuan [1] - The company has established a refining design capacity of 8 million tons per year, 21.5 million tons per year of PTA capacity, and 13.25 million tons per year of polymerization capacity [1] Group 2: Research and Development - Hengyi Petrochemical increased its R&D expenditure to 460 million yuan in the first half of 2025, a year-on-year increase of 23.97%, and submitted 300 invention patent applications during the reporting period [2] - As of June 30, 2025, the company holds 566 effective patents, including 500 R&D patents and 66 intelligent manufacturing patents [2] Group 3: Product Development and Market Position - The company is optimizing its polyester product structure, with differentiated fiber products accounting for 27% of its total production in the first half of 2025, leading the industry in differentiation [2] - Hengyi Petrochemical is focusing on the large-scale application of biodegradable fibers and high-value differentiated products, establishing multiple core patent technologies in areas such as ultra-cotton-like polyester fibers and transparent nylon materials [2] Group 4: Strategic Projects and Market Outlook - The Brunei refining project, with a capacity of 8 million tons per year, is the largest single investment project by a private Chinese enterprise overseas [3] - The ASEAN region is expected to maintain a GDP growth rate of 4.5% in 2025, which is higher than the global average, potentially driving demand for refining products [3] - The caprolactam-polyamide integrated project is expected to commence production in the second half of 2025 [3]

证券代码：000703 证券简称：恒逸石化 恒逸石化股份有限公司投资者关系活动记录表 编号：20250514 | | 特定对象调研 分析师会议 | | --- | --- | | 投资者关系 | 媒体采访  业绩说明会 | | 活动类别 | 新闻发布会 路演活动 | | | 现场参观 | | | 其他 （请文字说明其他活动内容） | | 参与单位名称 | 参与公司 年年度网上业绩说明会的投资者 2024 | | 及人员姓名 | | | 时间 | 年 月 2025 5 14 日，15：00—17：00 | | 地点 | 全景网"投资者关系互动平台"（http://ir.p5w.net） | | 上市公司接待 | 董事长、总裁：邱奕博 | | 人员姓名 | 副总裁、董事会秘书、财务总监：郑新刚 | | | 公司于 年 月 日 2025 5 14 15:00-17:00 在全景网"全景•路 | | | 演天下"（http://rs.p5w.net）举行 2024 年年度网上业绩说明 | | | 会。本次业绩说明会采用网络远程的方式举行，问答环节主 | | | 要内容如下： | | | 1、领导，您好 ...